Myomectomy During Cesarean Section Is This Aright Decision

Myomectomy During Cesarean Section,Is This Aright Decision

myomectomy was done during cesarean section

Study Overview

• Status: Completed
• Conditions: Obstetric Labor, Premature
• Intervention / Treatment: Procedure: myomectomy

Detailed Description

The myomectomy was done by conventional technique but timing of myomectomy either before or after delivery of the baby varied between different cases .Infusion of oxytocin during the operation and for 24 h later.

• Study Type: Observational
• Enrollment (Actual): 45

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: Female

• Sampling Method: Probability Sample

Study Population

c s with uterine myoma

Description

Inclusion Criteria:

• women with diagnosed uterine myoma prior to pregnancy
• needed cesarean sections for various indications.
• Women with diagnosed uterine myoma during pregnancy and needed cesarean sections for various indications.
• Women with myoma diagnosed incidentally during labour.

Exclusion Criteria:

• Refusal of the women at any time before and during the operations.
• Cervical myoma.
• Atonic uterus after delivery of the baby.
• Women with bleeding disorders due to medical or obstetric causes.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
difficulty of cesarean myomectomy	according to the site and type of myoma	during the procedure/surgery"

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
4concentrations of hemoglobin	intra operative bleeding	during the procedure

Collaborators and Investigators

• Sponsor: Benha University

Publications and helpful links

General Publications

• Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod. 2002 Jan;17(1):213-8. doi: 10.1093/humrep/17.1.213.

Study record dates

Study Major Dates

• Study Start (Actual): August 15, 2014
• Primary Completion (Actual): March 20, 2019
• Study Completion (Actual): September 15, 2019

Study Registration Dates

• First Submitted: April 29, 2020
• First Submitted That Met QC Criteria: May 13, 2020
• First Posted (Actual): May 15, 2020

Study Record Updates

• Last Update Posted (Actual): May 15, 2020
• Last Update Submitted That Met QC Criteria: May 13, 2020
• Last Verified: May 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pregnancy Complications; Obstetric Labor Complications; Obstetric Labor, Premature
• Other Study ID Numbers: khalid7

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: master sheet

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No